Ambalal Sarabhai Enterprises Limited (NSE:AMBALALSA)

Market Cap	3.08B +31.1%
Revenue (ttm)	2.06B +4.5%
Net Income	135.56M +5.8%
EPS	1.77 +8.6%
Shares Out	n/a
PE Ratio	22.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,998
Open	39.24
Previous Close	38.65
Day's Range	38.80 - 40.58
52-Week Range	30.15 - 49.98
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About NSE:AMBALALSA

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures and markets pharmaceutical, molecular diagnostics, and electronic products in India and internationally. The company is involved in the supply of pharmaceutical preparations, such as finished dosage forms and active pharmaceutical ingredients; manufacture of fermentation-based pharmaceutical products; and manufacturing and marketing analytical, laboratory, and test and measuring instruments. It also engages in the marketing and distributing professional broadcast...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 104
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMBALALSA

Financial Performance

In fiscal year 2026, NSE:AMBALALSA's revenue was 2.03 billion, an increase of 2.64% compared to the previous year's 1.97 billion. Earnings were 178.04 million, an increase of 261.05%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 24, 2026

Data Sources Report a data error